Dr. Syble Mcclellan Farringer is a pharmacist who is specialized in Pharmacotherapy in Birmingham, Alabama. Patients can reach her at 1813 6th Ave South, M152, Birmingham or contact her on 205-975-2477. Active license number of Dr. Syble Mcclellan Farringer is 11030 for Pharmacotherapy in Alabama. Dr. Syble Mcclellan Farringer is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Syble Mcclellan Farringer speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Syble Mcclellan Farringer are as mentioned below.
NPI Number:
1740289743
NPI Enumeration Date:
20 Jul, 2005
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Syble Mcclellan Farringer are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
11030
Alabama
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4736 Red Leaf Cir, Hoover, Alabama
Zip:
35226-4212
Phone Number:
205-823-8889
Fax Number:
--
Patients can reach Dr. Syble Mcclellan Farringer at 1813 6th Ave South, M152, Birmingham, Alabama or can call on phone at 205-975-2477.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.